Table 2.
MAI Criteria | N (%) |
---|---|
Indication | 0 (0) |
Effectiveness | 4 (3) |
Dosage | 15 (10) |
Directions | 1 (1) |
Practicality | 32 (21) |
Drug-Drug Interactions | 0 (0) |
Drug-Disease Interactions | 0 (0) |
Duplication | 2 (1) |
Duration | 2 (1) |
Expensiveness | 60 (39) |
Patients with Any of the | 99 (65) |
Above Criteria |